Close

Valeant Pharma (VRX), Subsidiary Commence Cash Tender Offers For Up to $1B Outstanding Principal Amount

December 4, 2017 7:22 AM EST Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Valeant Pharmaceuticals International ("VPI," and together with Valeant, the "Offerors"), a wholly-owned subsidiary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login